Iaf, Llc - Dec 29, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role: Member of 10% owner group
Signature: /s/ Edward Bennett, Authorized Signatory for IAF, LLC
Stock symbol: CMRA
Transactions as of: Dec 29, 2023
Transactions value $: $210,000
Form type: 4
Date filed: 1/5/2024, 05:59 PM
Previous filing: Jan 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	12.0% Senior Secured Convertible Notes	Purchase	$210K				$210K	Dec 29, 2023	Common Stock	3.82M	$0.06	Direct	F1
transaction	CMRA	Warrants to Purchase Common Stock	Purchase	$0	+7.64M		$0.00	7.64M	Dec 29, 2023	Common Stock	7.64M	$0.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.

Content

The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.